Dry January doesn't have to mean sober January — at least for the 21 percent of participants turning to cannabis or CBD to make it through the month.
According to a survey by Civic Science, 67 percent of Dry January participants, or those choosing to abstain from alcohol consumption for the month of January, reported they are replacing alcohol with something — whether that be mocktails and alcohol-free beers or sodas and seltzers.
The largest share, 21 percent, said they would enjoy cannabis or non-psychoactive CBD in place of alcohol. The preference for substitutes wasn't uniform across all respondents. Cannabis was the most popular substitute among the youngest respondents with 34 percent of 21- to 24-year-olds preferring it. Among the 55 and older crowd, by contrast, just 9 percent reported they'd enjoy cannabis or CBD instead of alcohol, and 54 percent reported they'd stay the course without any support.
Dry January's Growing Popularity
Interest in Dry January has climbed over the recent years. At the close of 2022, about 41 percent of respondents in a separate survey by Civic Science reported they were "somewhat to very likely" to participate in Dry January come 2023. That's in-line with pre-pandemic data for the start of 2020, but slightly behind 2022 responses, which rebounded after a lag in interest during the 2021 pandemic year.
As with the preference for cannabis, interest in Dry January tends to vary by age — and younger generations are leading the charge. For the year of 2023, more than half of the youngest respondents, aged 21 to 24 years old, said they were "somewhat to very likely" to participate versus just 41 percent of those 55 and older.
Studies suggest social media is contributing to a growing reluctance to drink with younger generations fearful of consequences if their drunk escapades are documented on the internet. According to 2019 research from Google, 49 percent of Generation Z reports their image online is "always at the back of their mind when they go out socializing and drinking." Some 76 percent reported it is important to have control of "all aspects of their life at all times," according to the research.
After two decades of engineering, over $10 billion, and a series of delays, the most powerful telescope built by NASA is finally scheduled to launch on Saturday. The James Webb Space Telescope was built to provide a fresh look at the universe by detecting light that is invisible to the human eye and to reveal new information about the universe's oldest stars and galaxies. Lou Strolger, observatory scientist and deputy head of instruments division, space telescope, joins Cheddar News.
Carlo and Baker kick off the weirdest week of the year with all the news you missed over the holiday weekend, including calls for the CDC to shorten its isolation window as Omicron sweeps through the country.
The 2022 Winter Olympics will be without some of hockey's biggest players. The NHL and the NHL Player's Association have agreed to not participate in the men's hockey tournament at the Games in Beijing next year. The league has been forced to postpone some games because of a rise in COVID-19 cases among players. Washington Post sports reporter Samantha Pell joins Cheddar News' Closing Bell to discuss what this could mean for the Winter Olympics and the sport of hockey.
The National Highway Traffic Safety Administration has opened a formal investigation into Tesla. The agency is looking into about 580,000 Tesla vehicles, and a feature called 'Passenger Play' which allows drivers to play video games on the center touch screen. The feature previously only worked when a vehicle was in park; but, the NHTSA says it has confirmed that the feature has been available while vehicles are in motion since December of 2020. iSeeCars.com executive analyst Karl Brauer joins Cheddar News' Closing Bell to discuss.
Baron Davis and Kate Hudson want you to bring cannabis home for the holidays. The cannabis-infused seltzer brand Cann released a new spot featuring the actress and former NBA player. The campaign comes hand in hand with Cann's launch of a new holiday bundle, which includes its product with Hudson's King Street Vodka. Davis and Hudson are also Cann investors. Cheddar cannabis reporter Chloe Aiello spoke to Davis about his involvement with the company and its new campaign.
Healthcare workforce management platform ShiftMed
recently announced a $45 million funding round.
The company's platform connects nurses and healthcare professionals to hospitals and other healthcare providers.
ShiftMed's new funding comes amid widespread labor shortages in the healthcare sector. The company's CEO Todd Walrath joins Cheddar News' Closing Bell to discuss.
Universities like UCLA, Yale, and Duke have announced they're implementing remote learning amid the COVID omicron variant surge, despite President Biden recommending that K-12 schools should continue in-person education. Jared C. Bass, senior director for Higher Education at American Progress, joined Cheddar to break down what institutions of higher education might be considering differently. "I think some universities are allowing periods of a bit of a respite to allow students to get testing and make sure when they do return back to campus that they're healthy," he noted.
Supply chain issues have become one of the biggest roadblocks for the U.S. EV market, with production woes likely to stunt the industry's growth in 2022. Rich Steinberg, electric vehicle expert and industry advisor, told Cheddar that the Biden administration investing in domestic mining for essential minerals used in battery manufacturing — such as lithium — could help alleviate the bottlenecks. "Some of those same materials are available domestically, they just haven't been prioritized," he said, noting the paradox between green tech and "dirty" mining. "The good news is that there are ways to extract those materials cleanly."
Hyperfine, the pioneer of the very first FDA-approved portable MRI device, made its public debut on the Nasdaq via a SPAC merger. CEO Dave Scott joined Cheddar's "Opening Bell" to discuss the IPO launch, the company's valuation at $580 million, and the impact of its machine called Swoop. "We can roll an MRI system, our MRI Swoop system, right into the room where you are, right up to your patient bedside, and scan you right there and get an image in less than an hour," he explained.
Dr. Rob Davidson, Executive Director of the Committee to Protect Health Care and an ER Physician in West Michigan, joins Cheddar News to break down the expectations of Pfizer's new COVID-19 treatment pill.
